Cargando…
The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535798/ https://www.ncbi.nlm.nih.gov/pubmed/33032845 http://dx.doi.org/10.1016/j.vaccine.2020.09.057 |
_version_ | 1783590460491563008 |
---|---|
author | Wolf, Jayanthi Hansen, Ryan Hassis, Kimberly Lapps, William Warmuth, Emese |
author_facet | Wolf, Jayanthi Hansen, Ryan Hassis, Kimberly Lapps, William Warmuth, Emese |
author_sort | Wolf, Jayanthi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7535798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75357982020-10-06 The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases Wolf, Jayanthi Hansen, Ryan Hassis, Kimberly Lapps, William Warmuth, Emese Vaccine Commentary Elsevier Ltd. 2020-10-27 2020-10-05 /pmc/articles/PMC7535798/ /pubmed/33032845 http://dx.doi.org/10.1016/j.vaccine.2020.09.057 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Wolf, Jayanthi Hansen, Ryan Hassis, Kimberly Lapps, William Warmuth, Emese The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases |
title | The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases |
title_full | The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases |
title_fullStr | The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases |
title_full_unstemmed | The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases |
title_short | The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases |
title_sort | impact of export regulations on recombinant viral vaccine development for emerging infectious diseases |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535798/ https://www.ncbi.nlm.nih.gov/pubmed/33032845 http://dx.doi.org/10.1016/j.vaccine.2020.09.057 |
work_keys_str_mv | AT wolfjayanthi theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT hansenryan theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT hassiskimberly theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT lappswilliam theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT warmuthemese theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT wolfjayanthi impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT hansenryan impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT hassiskimberly impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT lappswilliam impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases AT warmuthemese impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases |